Therefore, for small fields the total scatter factor is no longer equal to the ratio of detector readings. Thus, needs to be applied to correct the detector's response for small fields. Table 1 lists the k correction factors used in this study. Note that the k factors for the EDGE detector and the A16 chamber were derived for Siemens and Elekta machines 11 and those for the SFD were derived for Varian machines 12 . The original k factors published do not include all the field sizes used in this study, therefore interpolation was performed to obtain the k factors for some field sizes. 
B. Detectors and Devices
The Exradin A16 micro chamber has a collecting volume of 0.007 cm 3 , 1.7 mm outer shell collecting volume radius, 1.2 mm inner collecting volume radius, and 2.4 mm collecting volume length. It is constructed using air-equivalent plastic (C552) with a central electrode of silver-plated copper covered steel. The EDGE detector has an active area of 0.8x0.8 mm 2 and a thickness of 0.03 mm packaged in brass shielding. The SFD has an active area of 0.6 mm diameter and a thickness of 0.06 mm packaged in plastic ABS and epoxy resin. The EDGE is a shielded detector while the SFD is an unshielded detector.
C. Measurement Methods
Brainlab conical cones of 5, 7.5, 10, 12.5, 15, 17.5, 20, 25, 30 mm diameters are employed to collimate a 6 MV photon beam on a Varian Clinac iX linear accelerator for the stereotactic radiosurgery treatment at our institution. Measurements were performed using a scanning water phantom. Following the requirements of our planning system, the dose was measured at a depth of 1.5 cm with 98.5 cm SSD to the water surface. Beam profile scans along both transverse and radial directions were performed to ensure the centering of each detector prior to the output factor measurements. All output factors are normalized to a 10 x 10 cm 2 field, while a cross calibration technique (daisy chain method) was adopted for diode measurement results to account for differences of diode detector response between small and large photon fields. The intermediate field was the 3 cm cone field.
Results and Discussion
The original output factors measured before correction are shown in Table 2 and Fig. 1 . Large discrepancies up to 20% were observed for small fields, i.e., 5, 7.5 and 10 mm diameter cones. For fields larger than 10 mm, the discrepancies are less than 4%. The correction factors in Table 1 were applied to the output factors in Table 2 . The results are shown in Table 3 and Fig. 2 . After correction the discrepancies among various detectors are ~1% or smaller. The average of the corrected output factors are adopted for our SRS planning system. It can be seen that without correction, diodes overestimate the output factor for very small fields (especially the shielded EDGE detector). The A-16 ion chamber, one of the smallest ion chambers on the market, underestimates the output factors. Consistent output factors among the three detectors were obtained based on the correction factors in Table 1 though the correction factors were determined on various linacs. 
Introduction
Modern radiotherapy techniques make use of highly conformal dose distributions. This complexity limits the dose to normal tissues and permits the use of dose escalation in cases where it is clinically advantageous. A high degree of conformality is only useful if the patient position can be known with a high level of precision and accuracy. More stringent demands on the accuracy of the patient positioning have led to increased use of sophisticated image guidance techniques.
Kilovoltage cone beam computed tomography (CBCT) is one such technique that is routinely used for positioning verification. The CBCT x-ray system is mounted to the gantry and is typically used daily to acquire an image of the target volumes with the patient in the treatment position prior to treatment. A consequence of this technique is the high patient dose received from the kV-CBCT imaging relative to planar imaging techniques. While the dose from imaging is small relative to the treatment dose, routine use of these techniques can lead to significant dose to the normal tissues. Several studies have investigated the dose from kV-CBCT and have proposed methods to reduce the dose. It is however essential that image quality not be compromised such that it affects the accuracy of the image registration. This study evaluates the impact of a variety of imaging parameters on both the dose and the image quality of a clinical kV-CBCT system. It investigates how changes to the CBCT image settings can be used to reduce the patient dose while maintaining a comparable level of image quality.
Methods
All dose and image quality measurements were performed on an Elekta Synergy S linac (Elekta, Norcross GA) with XVI cone-beam CT. All dose measurements were taken on a single machine. The image quality measurements were performed on multiple XVI units using software versions 4.2.1 and 4.5. Flexmap, image offset and multi-level gain calibrations were performed before all measurements and collimation and filtration was unchanged across all measurements.
Dose measurement methodology was based on AAPM report 111 and used an NE2571 Farmer chamber in a 32cm x 45cm phantom consisting of three CTDI body phantoms place end-to-end. Doses were computed using the standard cone-beam dose index (CBDI) weighting (1/3 central dose + 2/3 peripheral dose) and with the alternative weighing proposed by Bakalyar. Image quality was assessed using a Catphan CTP500 phantom at isocentre and was based on the XVI4.5 customer acceptance test procedure.
Imaging presets were created for a range of exposure conditions based on the standard chest preset (120kV, 25mA, 40ms). Tube voltage was varied from 70 to 140kV in 8 steps, tube current was varied from 10 to 100mA in 11 steps and the number of projections was varied from 330 to 1243 frames in 6 steps. Nominal values of kV and mA were corrected using measured values acquired using an Unfors Xi system prior to plotting the data.
Results and Discussion
The effect of varying tube voltage was investigated by varying the nominal tube voltage from 70 to 140 kVp while leaving all other parameters unchanged. The standard CBDI is presented as a function of tube potential in figure 1. When tube potential is kept constant and only the tube current (mA) is varied, we find, as expected, a linear relationship between dose and tube current. The low contrast visibility shows that resolution improves as the tube current is increased. Figure 4 shows low contrast visibility vs dose and it is also seen that improvements in image resolution are limited with increases in tube current beyond a dose of about 20 mGy. As with varying the voltage, the image noise decreases sharply but shows little improvement beyond the initial drop. This is seen in figure 5 which plots standard deviation vs dose for three nominal tube potentials. In XVI v4.5, the software allows variation in the gantry speed which in turns controls the number of projections that will be used in the reconstruction. Keeping all other parameters constant, the dose increases linearly with the number of projections. Figure 6 shows the low contrast resolution as a function of the number of projections. As the number of projections increases, the low contrast visibility improves in spite of an increase in image noise as shown in In each of the above cases, there was little or no change observed in the high contrast resolution as each of the parameters was changed.
Conclusions
The dose from cone beam CT has been previously studied and these measurements confirm expectations that the dose will increase linearly with increasing tube current and number of projections. The increase in dose as a function of tube potential follows an exponential curve, indicating that the trade off for increasing tube voltage is higher beyond 90 or 120kVp. Improvements in image quality are generally achieved by increasing the dose, but the rate of improvement diminishes as the dose gets to the higher end of the range investigated. This suggests that in order to improve image quality, increases in kV or mA beyond standard clinical settings may not have a large enough effect on image quality to justify the additional patient dose. As treatment techniques rely more heavily on image guidance, care must be taken to establish clinical imaging protocols. Given the clear relationship between tube settings and dose, it must be stressed that changes to these parameters should be limited to cases where the image quality is insufficient at standard settings and where changes to the tube settings result in a clear improvement image quality. If no gain is achieved in the image resolution by increasing the dose, a lower setting should be used.
Introduction
The NRC primary standard for
192
Ir HDR brachytherapy sources is revised. The NRC has offered calibration services for these brachytherapy sources since 2011. The initial standard made use of the 7-distance technique and the cone-shadow method to determine the source-to-detector distance offset and the room scatter respectively. After removing the room scatter at each distance, the position offset was estimated by simple inspection until a small enough variation in the source strength S k was achieved. This approach suggested the room scatter to vary with distance and no uncertainty estimate was possible for the position offset determination. As a consequence, a rather conservative estimate of the total uncertainty was used. The present work relies on the multiple-distance method and a non-linear weighted least-squares-fit to determine all the unknown quantities, including S k , under the assumption of constant room scatter. This assumption has been shown in the literature to apply when the measuring setup is placed far enough from walls, ceiling and floor. The least-squares-fit provides the uncertainty of the estimated parameters allowing for more realistic uncertainty budget estimation. 192 Ir HDR microSelectron V2 seed at NRC is mounted on an HDR afterloader on loan from Nucletron. Airkerma rate for this source is measured using a graphite-walled spherical ionization chamber (2S). The inverse of Ir N k is obtained as the arithmetic mean of the inverse of the N k values for a 137 Cs beam and a medium filtered 250 kV xray beam quality (N250). Measurement of the source output at several source-detector distances can be used to determine the source strength, room scatter and positioning offset by means of a non-linear least-squares-fit, under the assumption of constant room scatter.
Methods

The
The measured signal, M raw , corrected for attenuation and scatter along the beam path and for point source divergence (Kondo-Randolph), can thus be fitted to the expression .
Where c is the positioning offset, M room , the room scatter, and f is the source strength S k per unit N k . The use of this analytical expression for M raw allows determining the covariance matrix and hence estimating the statistical uncertainties in the parameter estimation.
Results and Discussion
EGSnrc Monte Carlo (MC) simulations of the room scatter for a VariSource spectrum in a room with same dimensions as the NRC brachytherapy room confirm the assumption of room scatter constancy as shown on the left panel in Figure 1 . The right panel of Figure 1 shows a similar result for a bare 192 Ir source and a smaller room. Results of the non-linear least-squares fit of M raw using Grace are shown in the left panel of Figure 3 . On the right panel of this figure, the contribution of the lead wedge to the measured signal is estimated using MC simulation. As can be seen the use of this technique would require correcting for this contribution which is a much larger effect that the room scatter and positioning offset. If no correction is applied to the measured signal M raw , a deviation from the inverse distance squared can be observed in the red curve of Figure 4 . Furthermore, after applying all required corrections, an almost perfect inverse distance squared behavior is restored (black curve). Using the presented methodology in this work, the NRC determined value for S k is within 0.03% of the manufacturer's reported value. It is worth mentioning that the overall effect of all corrections is about 0.6%. Due to the averaging of Sk at all distances when using the shadow-cone method, no significant difference is observed between the previous approach the approach proposed here.
Conclusions
Under the assumption of constant room scatter, an analytical model can be used to directly estimate the required quantities for the determination of the source strength given by the air-kerma rate in vacuum times distance squared. The major source of uncertainty comes from the 0.45% uncertainty in the N k values for 137 Cs and the x-ray beam quality. The uncertainty in f from the non-linear least-squares-fit is about 0.4% and thus the statistical uncertainty in S k is about 0.6% (one sigma). We have chosen to only include the uncertainties which are directly related to the NRC determination of the source strength.
Introduction
Altered cellular metabolism is a hallmark of tumor cells 1 and contributes to a host of properties that are associated with resistance to conventional therapies, including radiation. Detection of radiation-induced biochemical changes can reveal specific metabolic pathways affecting radiosensitivity that may serve as attractive therapeutic targets. Novel technologies enabling the pre-treatment characterization and early monitoring of metabolic processes within tumour cells may provide significant opportunities for personalizing combined modality radiation therapy treatments in order to maximize the probability of disease response. One technique that has demonstrated great promise for metabolic analysis of tumour radiation response is Raman spectroscopy (RS). [2] [3] [4] RS is an optical technique that allows the characterization of the species presented in complex media by the vibrational signature of each molecular component. An optical laser is focused onto a sample, and the scattered Raman photons are collected and passed through a spectrometer for analysis. An advantage of RS is that live cells or tissues can be probed without requiring any fixation, staining, or molecular targeting (label-free). RS of intact cells can provide molecular information at levels of accuracy and sensitivity comparable to other established techniques such as magnetic resonance spectroscopy and flow cytometry. 5 The molecular specificity of RS allows the simultaneous detection of signals from proteins, nucleic acids, lipids, and carbohydrates (e.g., glycogen) in a single acquisition, allowing complex molecular changes in cells to be analyzed simultaneously across different classes of biomolecules and therefore bypassing certain difficulties inherent to staining or molecular targeting methods. Furthermore, RS can be directly applied in vivo with the use of minimally invasive fiber-optic probes. 6 Recent work [2] [3] [4] demonstrated that single-cell RS techniques applied to cells irradiated in vitro with single high doses of radiation (15 to 50 Gy) can detect radiation-induced molecular and metabolic changes in human tumour cell lines. Using principal component analysis (PCA), radiation-induced changes were distinguished from concurrent changes arising from cell cycle processes. 3, 4 Furthermore, RS radiation response signatures were shown to segregate the cell lines tested according to radiosensitivity and p53 gene status. 4 The aims of the present study are threefold: (1) to extend these previous RS methods to clinically relevant doses (2 to 10 Gy) using both radioresistant and radiosensitive tumour cell lines, (2) to demonstrate early RS detection of radiation-induced glycogen synthesis in radioresistant cell lines, and (3) to co-treat the radioresistant cells with the anti-diabetic drug metformin to demonstrate that early RS monitoring of radiation-induced glycogen synthesis correlates with the radiosensitizing effect of the combined modality treatment. Methods Three human tumour cell lines, two radioresistant (H460, SF 2 = 0.57 and MCF7, SF 2 = 0.70) and one radiosensitive (LNCaP, SF 2 = 0.36), were irradiated to 2, 4, 6, 8 or 10 Gy with single fractions of 6 MV photons. In additional experiments, H460 and MCF7 cells were irradiated 1 hour after incubation with 5 mM of the anti-diabetic drug metformin. Treated and control cultures were analyzed with RS daily up to 3 days post-treatment. Single-cell Raman spectra were acquired from 20 live cells per sample using previously described techniques, 2 and experiments were repeated in triplicate. The combined data sets (up to 3240 cell spectra per data set) were post-processed 2 and analyzed with principal component analysis using standard algorithms. Cells from each culture were also subjected to standard assays 2, 8 for viability, proliferation, cell cycle distribution, and radiation clonogenic survival.
Results and Discussion
RS detection of early radiation-induced glycogen synthesis in radioresistant tumour cells:
Single-cell Raman analysis of 2-10 Gy irradiated H460, MCF7 and LNCaP cells at 1 to 3 days post-irradiation revealed radiationinduced synthesis of glycogen in H460 and MCF7 cells, but not LNCaP cells. Figure 1A shows representative irradiated and unirradiated H460 cell Raman spectra collected at 3 days post-irradiation. The point-by-point difference spectrum and the first PCA component from the entire Raman data set are both dominated by Raman spectral features of glycogen (solid black trace in Figure 1A ). The first PCA component explains 40.9% of the total variance, and represents the variability in intra-cellular glycogen content within the complete Raman data set of 3240 single-cell spectra. The mean PCA scores for the first PCA component ( Figure 1B) indicate that statistically significant (p<0.05 by unpaired two-tailed t-test) increases in intra-cellular glycogen, relative to same-day unirradiated cells, occur for all radiation doses at days 1-3 for H460 cells and at days 2-3 for MCF7 cells, but not at any day for LNCaP cells. Radiation effects on proliferation, cell death, and cell cycle redistribution were similar for each cell line (data not shown). However, radiation clonogenic survival assays indicated that both H460 and MCF7 cells are significantly more radioresistant than LNCaP cells ( Figure 1C ). As such, we hypothesize that radiationinduced glycogen synthesis is a biomarker for increased radioresistance in human tumour cells.
Metformin co-treatment of radioresistant tumour cells:
One hour prior to irradiation, H460 and MCF7 cells were incubated with 5 mM of the anti-diabetic drug metformin, which has previously been shown to radiosensitize MCF7 tumour cells via activation of signaling pathways also known to inhibit glycogen synthesis. 7 Co-treatment with metformin had little effect on radiation-induced glycogen synthesis in H460 cells (Figure 2A ), whereas in MCF7 cells glycogen synthesis was dramatically reduced ( Figure 2B) . A representative reduction in the RS glycogen signal for co-treated MCF7 cells is shown in Figure 2C . Co-treatment in H460 cells had no deleterious effects on cell proliferation or viability, whereas co-treated MCF7 cells exhibited significantly reduced proliferation and increased cell death (Figures 2D and 2E) . Finally, clonogenic assays demonstrated no effect of metformin co-treatment on the radiosensitivity of H460 cells ( Figure 2F ), whereas MCF7 cells were significantly radiosensitized ( Figure 2G ). Conclusions Label-free RS is well suited for early detection of glycogen synthesis post-irradiation, a previously undocumented metabolic mechanism that is (1) associated with tumour cell radioresistance, and (2) can be targeted to increase radiosensitivity. In this work, RS monitoring of radiation-induced glycogen synthesis was found to correlate with the efficacy of the targeted co-treatment strategy. RS monitoring of intratumoral glycogen levels in radiotherapy patients may provide new opportunities for personalized combined modality treatments. 
Introduction
Volumetric-modulated arc therapy (VMAT) has been rapidly adopted by the radiotherapy community due primarily to its delivery speed and monitor unit (MU) efficiency, as well as the conformal dose distributions it can achieve [1] . On the other hand, intensity-modulated radiotherapy (IMRT) with its static beam directions might be advantageous in cases where steep dose gradients or highly intensity-modulated beam intensities are required in certain preferred directions [2] . While the community tends to regard these two delivery techniques as disparate entities, they are in reality special cases of one another. More specifically, there exists a unifying delivery technique which bridges the gap between VMAT and static-gantry IMRT. Such a unified delivery, if properly implemented into an inverseplanning algorithm, would in general lead to improved dose delivery capabilities as the algorithm could naturally tune the beam within a given arc range to be more IMRT-like, if increased modulation is required, or more VMATlike, if increased conformity is required. The purpose of this work is to study the feasibility of a unified intensitymodulated arc therapy (UIMAT) that combines IMRT and VMAT optimization and delivery in the same arc for producing efficient and superior radiation treatment plans.
Methods
The optimization of UIMAT was started by creating static beams uniformly spaced at certain degree increments (24 degrees was used for this initial study) between the user-selected start and stop angles. IMRT objectives were then created using the standard Pinnacle inverse-planning user interface (Philips Medical System), after which fluence optimization was initiated. Conversion to deliverable MLC segments was then carried out with appropriate conversion parameters. After creating MLC segments, a direct machine parameter optimization (DMPO) step was performed. After this step, customized software was used to redistribute these control points into a UIMAT beam.
During UIMAT conversion, any beam with four or more control points was converted into a slow-moving arc with 0.1 degree control point spacing (termed the IMRT phase). The remaining beams were joined into multiple partial arcs with standard 4 degree control point spacing, representing the standard VMAT phase. Certain "soft" deliverability constraints, for example the maximum MU per degree, were relaxed for the IMRT-like portions of delivery. This was required in order to have a reasonable number of MUs delivered during the IMRT phase, which may have up to five control points within a single degree spacing. It is important to note that such a beam is still machine-deliverable as it does not violate any physical constraints. From this point on, optimization proceeds using the standard functionality within Pinnacle. DMPO optimization is continued until an optimized plan is obtained.
Five treatment plans each for prostate, head and neck, and lung were generated using our UIMAT technique and compared with clinical VMAT or IMRT plans. Delivery verification was performed on an ArcCheck phantom and delivered in clinical mode on a Varian TrueBeam linear accelerator.
Results
The UIMAT plans were generated for 15 cases as shown in Table 1 . In general, UIMAT uses only one arc instead of two arcs compared with VMAT plans. The numbers of MLC control points are less than VMAT plans but more than IMRT plans. The estimated delivery times for UIMAT plans are similar to VMAT plans and are expect to be faster than multiple-field IMRT plans due to extra time required to mode up individual IMRT field. As a example, comparison of dose distributions and DVHs between VMAT and UIMAT plans for a head and neck case are shown in Figure 1 and Figure 2 respectively. The dosimetric parameters are given in Table 2 , showing UIMAT plans have lower doses for most OARs compared to VMAT plans with similar dose coverage to PTVs. Abbreviations: : D0.1cc = minimum dose to the hottest 0.1 cm 3 non-contiguous volume; V105% = volume receiving at least 105% of the prescription dose; CI = conformity index; = mean dose; Clin = clinical plan; UIMAT = unified intensity-modulated arc therapy plan; Rt = Right; Lt = Left.
Conclusions
In this proof-of-concept work, we demonstrated that a novel radiation therapy delivery technique UIMAT which combines VMAT and IMRT delivery in the same arc is feasible. Initial results showed UIMAT has the potential to be superior to either standard IMRT or VMAT.
Introduction
The overall goal of radiation therapy (RT) is to maximize the dose to the tumour while minimizing dose to the surrounding normal tissue. Highly conformal radiation dose distributions can be achieved with techniques such as intensity modulated radiation therapy (IMRT). However, sources of treatment uncertainties include patient set-up variability, inter and intra-fractional organ motion [1] , and organ deformation [2] . Intrafractional motion due to breathing is addressed using four-dimensional computed tomography (4DCT) [3] . In one approach, the 4DCT is used to define the internal gross tumour volume (IGTV), the region that encompasses the entire GTV throughout the respiratory cycle. The IGTV is then expanded for subclinical disease to obtain the internal target volume (ITV). Other uncertainties including patient set-up error, anatomical motion that is not due to breathing and machine inaccuracies are addressed by adding a margin around the ITV to obtain the planning target volume (PTV).
The use of image guided radiotherapy (IGRT) has the potential to reduce margins, in turn reducing radiation toxicity and allowing dose escalation which has shown to improve local control and survival [4] . For example, the advent of linear accelerator-mounted cone-beam computed tomography (CBCT) has provided volumetric images to address tumour position and surrounding organs at risk [5] . Following patient set-up, CBCT images are registered with the planning CT using automated rigid image registration, and the resulting x, y, z shift is applied to the treatment couch to correct patient position prior to treatment. Despite these advancements, smaller PTV margins come at the expense of increasing the chance of a geometrical miss [1] . It is important to optimize PTV margins to ensure sufficient target coverage with minimal exposure of normal tissue.
Methods
This study analyzed data from 18 patients who received conventional lung RT with CBCT image guidance at our institution from January 2012 to September 2013. When tumour motion due to breathing was a concern, a 4DCT was acquired along with a free-breathing planning image using a Phillips Brilliance Big Bore CT scanner (Phillips Healthcare, Andover, MA) with 3.0 mm slice thickness. A maximum intensity projection (MIP) image was also generated from the reconstructed 4DCT dataset.
The ITV was contoured by the radiation oncologist using the MIP image. To safely account for patient set-up error and daily anatomical changes, a 1 cm margin was added to the ITV to obtain the PTV. Three-dimensional conformal or intensity modulated radiation therapy plans were developed using Pinnacle v9.2 (Phillips Healthcare, Andover, MA) and were optimized such that 95% of the PTV receives at least 90% of the prescription dose.
All patients were treated on Varian Clinac (Varian Medical Systems, Inc., Palo Alto, CA) linear accelerators equipped with the on-board imaging (OBI) system for kV CBCT acquisition [low dose thorax mode was used]. Daily pre-treatment CBCT images were obtained after patient set-up. Rigid image registration of the spinal anatomy between the pre-treatment CBCT and planning CT was performed. Each result was manually assessed to ensure matching was accurate along the spinal cord and carina, and that the visible target was within the PTV. The patient was repositioned if the translational and rotational differences between planning and treatment exceeded 15 mm and 5 degrees, respectively. Otherwise, translations between 2 and 15 mm were recorded and a translational couch shift was applied prior to treatment. A weekly post-treatment CBCT image was also acquired.
Polygonal meshes were generated from the contours of the ITV in the treatment planning system (TPS) for each patient to represent the surface of the ITV. The clinical couch shifts were calculated as the difference between the couch positions (longitudinal, lateral, and height) of the post and pre-treatment CBCT images. This couch shift was applied to the previously obtained pre-treatment CBCT to obtain a set of data for each fraction now consisting of three CBCT images: 1. pre-couch shift; 2. pre-treatment, post-couch shift; 3. post-treatment.
Deformable image registration (DIR) was used to register the planning data to each CBCT image. First, the average planning dataset was globally registered with the CBCT image to account for rotations, translations, and scalings. A previously validated DIR algorithm [6] was then used to fully register the data. The resulting transformation from the DIR was applied to the ITV surface to obtain a deformed ITV surface for each fraction. Treatment success was quantified by determining the percentage of the treatment ITV surface vertices within the evaluation PTV margin. Furthermore, we determined a margin that provided a suitable level of ITV coverage over an appropriate percentage of fractions. Statistical analyses were conducted to quantify the benefit of CBCT imaging, effects of intrafractional motion, and optimal PTV margins.
Results
Typical results obtained using deformable image registration are shown in Figure 1 while Figure 2 demonstrates how target coverage was assessed. Figure 3 shows the percentage of treatment fractions where at least 99% of the ITV fell within the PTV (thus the ITV is believed to have received the prescribed dose). 
Discussion
Our treatment success was defined as a situation where at least 99% of the ITV is covered by the PTV. Although this criterion may be arbitrarily chosen, it is supported by a study conducted by Guckerberge et al. [7] who proposed a PTV margin such that tumour drifts were less than a certain tolerance in 90% of all fractions. Actually, this criterion appears to be conservative as indicated by the results of van Sornsten de Koste et al. [8] which showed sufficient dosimetric coverage for geometrical coverage less than 99% accuracy. Figure 3 demonstrates the importance of CBCT image guidance. The current approach with a 1 cm PTV margin was successful ~96% of the time. A 0.8 cm isotropic margin was successful ~92% of the time. A 0.5 cm margin only contained the ITV in ~ 75% of the fractions in contrast to the zero geometrical misses using a 0.5 cm isotropic PTV margin observed by Higgins et al. [9] This difference may be attributed to the capability of DIR to detect smaller geometrical changes (Figures 1 and 3 ) compared to the rigid registration analysis performed by Higgins et al. [9] Non-isotropic margins were also evaluated. The 0.6 x 0.6 x 1.0 cm 3 margin (0.6 cm in plane, 1 cm craniocaudal) was found to be successful ~91% of the time. This margin demonstrated statistically significant accuracy improvement when CBCT imaging was employed and demonstrated insignificant losses in accuracy during the treatment fraction.
This study presents a comprehensive method for retrospectively analyzing IGRT data to optimize treatment margin. Applying this analysis to our clinical data shows that a 0.8 cm isotropic or 0.6 x 0.6 x 1.0 cm 3 non-isotropic PTV margin is appropriate. The advantage of the latter is that it allows treatment of targets closer to the esophagus and spinal cord.
